Press release
Immune Repertoire Sequencing Market Show Significant Demand; Analysis By Top Players Thermo Fisher Scietific, Illumina Inc., ArcherDX, Inc., Roche Holding AG, Juno Therapeutics, Pacific Biosciences, CD Genomics, Atreca, Inc., and Adaptive Biotechnologies
Global Immune Repertoire Sequencing Market
Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1517
Immune Repertoire Sequencing Market: Drivers
Increasing research and development and launches of novel products by key players in market is expected to be the major driving force for growth of global immune repertoire sequencing market in the near future. For instance, in 2016, ArcherDX, Inc., a U.S.-based company, expanded its product portfolio with the launch of its latest Archer Immunoverse immune repertoire sequencing assays at the American Society of Hematology (ASH). In 2017, ArcherDX, Inc. launched its latest Archer Immunoverse B Cell Receptor (BCR) assays to characterize the human B cell repertoire. In 2017, researchers from Stanford University applied immune repertoire sequencing to identify disease-related signatures in the immune systems of patients with systemic sclerosis with pulmonary hypertension (SSc-PAH), a rare chronic autoimmune disease that affects the connective tissue. Increasing research on immune repertoire sequencing is expected to create a conducive environment for growth of immune repertoire sequencing market in the near future. Recently, immune repertoire sequencing has been applied for the development of cancer biomarkers and immunotherapies. Therefore, increasing prevalence of cancer is expected to positively drive growth of immune repertoire sequencing market.
Immune Repertoire Sequencing Market: Key Players
Key players in global immune repertoire sequencing market include Thermo Fisher Scietific, Illumina Inc., ArcherDX, Inc., Roche Holding AG, Juno Therapeutics, Pacific Biosciences, CD Genomics, Atreca, Inc., and Adaptive Biotechnologies. Major players in the market are involved in strategic partnership and collaborations, in order to develop and provide immune repertoire sequencing services to customers. For instance, in March 2018, ArcherDX Inc. and Ambry Genetics entered into strategic partnership to provide immune repertoire sequencing services to biopharmaceutical customers. As per the partnership agreement, Ambry Genetics will use ArcherDX's Immunoverse and VariantPlex next-generation sequencing assays for immune repertoire sequencing.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1517
Immune Repertoire Sequencing Market Taxonomy:
The global immune repertoire sequencing market is segmented on the basis of product type, application, end user, and region.
By Product Type:
• Instruments
• Reagents and Kits
By Application:
• Cancer Immunotherapy
• Infectious Disease
• Asthma And Allergy
• Biomarker Discovery
• Organ Transplant
• Immune Response
• Autoimmune Diseases
• Others
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immune Repertoire Sequencing Market Show Significant Demand; Analysis By Top Players Thermo Fisher Scietific, Illumina Inc., ArcherDX, Inc., Roche Holding AG, Juno Therapeutics, Pacific Biosciences, CD Genomics, Atreca, Inc., and Adaptive Biotechnologies here
News-ID: 1366580 • Views: …
More Releases from Coherent Market Insights - Biotechnology
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027."
Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial…
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used…
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness…
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies.
Free Request Sample Copy…
More Releases for Immune
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts…
Immune Checkpoint Inhibitor
Immune Checkpoint Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and indepth study on the current state of the global Immune Checkpoint Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Immune Checkpoint Inhibitors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an…
Immune Health Supplements: Best Way to Boost Your Immune System
ResearchMoz include new market research report "Global Immune Health Supplements Market Research Report 2019" to its huge collection of research reports.
Immune Health Supplements refer to the product which could improve human immune health.
The global Immune Health Supplements market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
Learn more Through Sample Report…
BOC Sciences Diversifies Immune Checkpoint Inhibitors and Nonspecific Immune Sti …
Headquartered in Shirley, New York, the world’s reputed chemical supplier BOC Sciences announced to diversify its immune checkpoint inhibitors as well as nonspecific immune stimulation targets for scientific research targeting cancer immunotherapy (https://www.bocsci.com/tag/cancer-immunotherapy-36.html) on August 29, 2018.
Traditionally, surgery, chemotherapy and radiotherapy are the most widely chosen therapies in cancer treatment. However, in recent years, immunotherapy has attracted increasing attention among the research community. Immunotherapy agents do not directly…
Immune Health Supplements Market
The immune health supplements apart from providing resistance to infection and disease, also provide preventive measures that help to maintain immune system. The immune system is a complicated network of various functions, which all together help to prevent against infective agents such as pathogenic bacteria and viruses. Healthy immune system easily recognizes foreign agents. The cells of immune system are different which mainly include the lymphocytes, or T-cells that fight…
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy
1.1 Overview
1.2 History- From Tragedy to Breakthrough
Major Immune Checkpoints Proteins
2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development
2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development
Mechanism of Action of Immune Checkpoint Inhibitors
3.1 Cytotoxic T lymphocyte Antigen-4…
